Home/Filings/4/0001209191-21-063386
4//SEC Filing

WINSTON ROY 4

Accession 0001209191-21-063386

CIK 0001396814other

Filed

Nov 7, 7:00 PM ET

Accepted

Nov 8, 4:22 PM ET

Size

7.3 KB

Accession

0001209191-21-063386

Insider Transaction Report

Form 4
Period: 2021-11-04
WINSTON ROY
Chief Clinical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-11-04$48.15/sh+10,000$481,50046,456 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-11-0410,00015,000 total
    Exercise: $48.15Exp: 2027-05-02Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years.

Issuer

Pacira BioSciences, Inc.

CIK 0001396814

Entity typeother

Related Parties

1
  • filerCIK 0001751757

Filing Metadata

Form type
4
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 4:22 PM ET
Size
7.3 KB